News | July 26, 2024
Glenmark Life Sciences posts Q1 FY25 PAT at Rs. 111.48 Cr
Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024
Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9)
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Poly Medicure has reported total income of Rs. 401.69 crores during the period ended June 30, 2024
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
RPG Life Sciences has reported total income of Rs. 167.79 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
